Literature DB >> 9803337

Pulmonary infections associated with systemic capillary leak syndrome attacks in a patient with hypogammaglobulinemia.

K Lassoued1, J P Clauvel, T Similowski, B Autran, D Bengoufa, E Oksenhendler.   

Abstract

Systemic capillary leak syndrome (SCLS) is a rare disorder of unknown etiology, characterized by recurrent hypovolemic shock attacks associated in most cases with a serum monoclonal immunoglobulin. Prophylactic therapy is usually disappointing and the outcome is often fatal. We report on a patient with recurrent hypovolemic shocks consistent with the diagnosis of SCLS associated with severe serum panhypogammaglobulinemia but no detectable monoclonal immunoglobulin or B cell proliferation. Attacks were often preceded by severe respiratory infections. Both infections and attacks were successfully prevented by i.v. gammaglobulin replacement. Further evaluation is needed to assess the efficacy of i.v. gammaglobulins in patients with SCLS but without hypogammaglobulinemia.

Entities:  

Mesh:

Year:  1998        PMID: 9803337     DOI: 10.1007/s001340050700

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  13 in total

1.  The systemic capillary leak syndrome: appearance of interleukin-2-receptor-positive cells during attacks.

Authors:  M Cicardi; M Gardinali; G Bisiani; A Rosti; P Allavena; A Agostoni
Journal:  Ann Intern Med       Date:  1990-09-15       Impact factor: 25.391

2.  Control of systemic capillary leak syndrome with aminophylline and terbutaline.

Authors:  R M Droder; R A Kyle; P R Greipp
Journal:  Am J Med       Date:  1992-05       Impact factor: 4.965

3.  Systemic capillary leak syndrome with monoclonal IgG and complement alterations. A case report on an episodic syndrome.

Authors:  C G Löfdahl; L Sölvell; A B Laurell; B R Johansson
Journal:  Acta Med Scand       Date:  1979

4.  Fulminating systemic capillary leak syndrome with lymphocytosis and hypogammaglobulinemia.

Authors:  P M Kang; C Lawrence; G A Khan; R M Hays
Journal:  Ren Fail       Date:  1995-09       Impact factor: 2.606

Review 5.  Treatment of autoimmune diseases with normal immunoglobulin through manipulation of the idiotypic network.

Authors:  N Ronda; S V Kaveri; M D Kazatchkine
Journal:  Clin Exp Immunol       Date:  1993-09       Impact factor: 4.330

6.  Production of 5-lipoxygenase pathway metabolites by peripheral leucocytes in capillary leak syndrome (Clarkson disease).

Authors:  E Rondeau; J Sraer; M Bens; L M Doleris; R Lacave; J D Sraer
Journal:  Eur J Clin Invest       Date:  1987-02       Impact factor: 4.686

7.  Muscle biopsy findings in systemic capillary leak syndrome.

Authors:  C Navarro; F García-Bragado; J Lima; J M Fernández
Journal:  Hum Pathol       Date:  1990-03       Impact factor: 3.466

8.  A phase I study of an anti-CD22-deglycosylated ricin A chain immunotoxin in the treatment of B-cell lymphomas resistant to conventional therapy.

Authors:  P L Amlot; M J Stone; D Cunningham; J Fay; J Newman; R Collins; R May; M McCarthy; J Richardson; V Ghetie
Journal:  Blood       Date:  1993-11-01       Impact factor: 22.113

9.  Systemic capillary leak syndrome.

Authors:  M A Barnadas; A Cisteró; D Sitjas; E Pascual; X Puig; J M de Moragas
Journal:  J Am Acad Dermatol       Date:  1995-02       Impact factor: 11.527

10.  Capillary leak syndrome likely the result of granulocyte colony-stimulating factor after high-dose chemotherapy.

Authors:  E Oeda; K Shinohara; S Kamei; J Nomiyama; H Inoue
Journal:  Intern Med       Date:  1994-02       Impact factor: 1.271

View more
  5 in total

1.  Idiopathic systemic capillary leak syndrome preceding diagnosis of infiltrating lobular carcinoma of the breast with quiescence during neoadjuvant chemotherapy.

Authors:  Kalman P Bencsath; Frederic Reu; Jill Dietz; Eric D Hsi; Gustavo A Heresi
Journal:  Mayo Clin Proc       Date:  2011-03       Impact factor: 7.616

2.  High-dose intravenous immunoglobulins: a promising therapeutic approach for idiopathic systemic capillary leak syndrome.

Authors:  Manuel Zipponi; Roland Eugster; Tanja Birrenbach
Journal:  BMJ Case Rep       Date:  2011-05-03

3.  Idiopathic systemic capillary leak syndrome (Clarkson's disease): the Mayo clinic experience.

Authors:  Prashant Kapoor; Patricia T Greipp; Eric W Schaefer; Sumithra J Mandrekar; Arif H Kamal; Natalia C Gonzalez-Paz; Shaji Kumar; Philip R Greipp
Journal:  Mayo Clin Proc       Date:  2010-07-15       Impact factor: 7.616

Review 4.  [Idiopathic systemic capillary leak syndrome (Clarkson disease) : A rare cause of recurrent life-threatening edema].

Authors:  S Dasdelen; S-O Grebe
Journal:  Internist (Berl)       Date:  2018-07       Impact factor: 0.743

Review 5.  Raised Serum Levels of Syndecan-1 (CD138), in a Case of Acute Idiopathic Systemic Capillary Leak Syndrome (SCLS) (Clarkson's Disease).

Authors:  Ole Wilhelm Bøe; Kjell Sveen; Magne Børset; Kirk M Druey
Journal:  Am J Case Rep       Date:  2018-02-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.